Dataset from Phase 1: A Single-Center, Randomized, Blinded, Placebo-Controlled, Single-Administration, Sequential-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007176
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to determine the safety/tolerability profile, systemic
PK behavior, and immunogenicity of single IV and SC administrations of BG00010 to sciatica
participants.
创建时间：
2025-07-07
